The landscape of trials for smoldering multiple myeloma: endpoints, trial design, and lessons learnt

Ghulam Rehman Mohyuddina Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Westwood, KS, USACorrespondence[email protected]

Evguenia Ouchveridzea Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Westwood, KS, USA

Aaron Goodmanb Division of Blood and Marrow Transplantation, University of California San Diego, La Jolla, CA, USA

Vinay Prasadc Divisions of Hematology & Medical Oncology, University of California San Francisco, CA, USA

Click to increase image sizeClick to decrease image size

Disclosure statement

Vinay Prasad reports royalties from Johns Hopkins Press, Medscape, MedPage, consulting for UnitedHealthcare, and speaking fees for Evicore. Vinay Prasad has a plenary session podcast that has Patreon backers. Vinay Prasad is funded to study low value drugs through a grant from Arnold Ventures. Aaron Goodman reports consulting for Seattle Genetics and EUSA Pharma. None of the authors have any other conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

The landscape of trials for smoldering multiple myeloma: endpoints, trial design, and lessons learnt

Information for

Open access

Opportunities

Help and information

The landscape of trials for smoldering multiple myeloma: endpoints, trial design, and lessons learnt

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature